Company intelligence / Profile preview

Frequency Exchange

Vancouver, British Columbia, Canada

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Frequency Exchange Corp. develops and commercializes wearable frequency emitters designed to deliver specific frequency sets indicated for chronic Lyme disease, sleep improvement, stress/anxiety reduction, and pain/inflammation relief. Its fifth-generation device, NIKKI, and previous device, Wave 1, target wellness and symptom management, including clinical use for Lyme disease[1][2][5].

Therapeutic areas: PsychiatryImmunologyInfectious DiseasesNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Undisclosed strategic global partnerships (2025 expansion)[6]

Beyond the preview

Go deeper on Frequency Exchange.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frequency Exchange.

Explore the full profile